News & Updates
Filter by Specialty:
Polypill strategy triumphs in reducing MACE post-MI
12 Sep 2022
byRoshini Claire Anthony
A polypill comprising aspirin, ramipril, and atorvastatin, significantly reduced the incidence of major adverse cardiovascular (CV) events in patents with a recent myocardial infarction (MI), according to results of a phase III trial presented at ESC 2022.
Polypill strategy triumphs in reducing MACE post-MI
12 Sep 2022Antihypertensive drugs confer durable BP reduction in white-coat hypertension
11 Sep 2022
Antihypertensive medications prove to be effective and lasting in decreasing office blood pressure (BP) among individuals with white-coat hypertension (WCH), suggests a study.
Antihypertensive drugs confer durable BP reduction in white-coat hypertension
11 Sep 2022Thrombocytopaenia, platelet dysfunction common in Parkinson’s disease
10 Sep 2022
Despite having no such history, about a third of patients with Parkinson’s disease (PD) show evidence of thrombocytopaenia or platelet dysfunction, reports a recent study.